Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has ...
Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has granted marketing authorizations for Teva's biosimilars PONLIMSI and DEGEVMA e ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback